date:Aug 13, 2014
. The newly appointed management board will present a strategic update in November.
Both sales and EBITDA grew organically in the 2nd quarter compared to Q2 2013. Similar to the 1st quarter, a contrasting performance was visible between both market segments: The performance in Biochemicals excelled in volumes and margins, while Biobased Food Ingredients, showing some improvement versus Q1, continued to disappoint. We are currently in the middle of a thorough strategic process, the outcome of wh